What does the evidence say about Artichoke Leaf Lipid Markers Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Artichoke Leaf Lipid Markers Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - A limited number of studies have reported that exposure to diethylnitrosamine (DEN), which is commonly found in processed/preserved foods, causes biochemical abnormalities in the brain. [Cicek B (2022); evidence level 4] - Artichoke significantly improved the levels of Klotho and PPARγ, which are neuroprotective factors, in mouse brain tissue exposed to DEN. [Cicek B (2022); evidence level 4] - In addition, caspase-3 and Bax levels were reduced, whereas the Bcl-2 level was elevated with artichoke treatment. [Cicek B (2022); evidence level 4] - (1) Background: Various epidemiological studies suggest that oxidative stress and disrupted neuronal function are mechanistically linked to neurodegenerative diseases (NDs), including Parkinson's disease (PD) and Alzheimer's disease (AD). [Cicek B (2022); evidence level 4] - The levels of triglycerides and cholesterol were significantly reduced in the group treated with Cynara scolymus when compared to placebo group. [Rangboo V (2016); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.